Protective effects of a neurotrophic ACTH((4-9)) analog on cisplatin ototoxicity in relation to the cisplatin dose: An electrocochleographic study in albino guinea pigs

Hearing Research

Volumn 124, Issue 1-2, 1998, Pages 108-117

  Stengs, Cornelis H M ^a   Klis, Sjaak F L ^a   Huizing, Egbert H ^a   Smoorenburg, Guido F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cisplatin; Cochlear microphonics; Compound action potential; Guinea pig; Ototoxicity; Prophylaxis; Summating potential

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOTROPIN DERIVATIVE;

ACTION POTENTIAL; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; COCHLEA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROOCULOGRAPHY; FEMALE; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ACTION POTENTIALS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTINEOPLASTIC AGENTS; AUDIOMETRY, EVOKED RESPONSE; CISPLATIN; COCHLEAR MICROPHONIC POTENTIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; GUINEA PIGS; PEPTIDE FRAGMENTS;

EID: 0031729011     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00130-0     Document Type: Article

References (24)

1. Bodenner D.L., Dedon P.C., Keng P.C., Katz J.C., Borch R.F. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer Res. 46:1986;2751-2755.
2. Chary K.K., Higby D.J., Henderson E.S., Swinerton K.D. Phase I study of high dose cis-dichlorodiammine-platinum(II) with forced diuresis. Cancer Treat. Rep. 61:1977;367-370.
3. Church M.W., Kaltenbach J.A., Blakley B.W., Burgio D.L. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear. Res. 86:1995;195-203.
4. (4-9) analogue, ORG2766, may reduce the cochleotoxic effects of cisplatin. Hear. Res. 106:1997;9-19.
5. De Koning P., Neijt J.P., Jennekens F.G.I., Gispen W.H. ORG2766 protects from cisplatin-induced neurotoxicity in rats. Exp. Neurol. 97:1987;746-750.
6. Gandara D.R., Wiebe V.J., Perez E.A., Makuch R.W., DeGregorio M.W. Cisplatin rescue therapy: Experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate. Crit. Rev. Oncol. Hematol. 10:1990;353-365.
7. Gerritsen van der Hoop R., Vecht C.J., Van der Burg M.E.L., Elderson A., Boogerd W., Heimans J.J., Vries E.P., Van Houwelingen J.C., Jennekens F.G.I., Gispen W.H., Neijt J.P. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. New Engl. J. Med. 322:1990;89-94.
8. Gispen W.H. Therapeutic potential for melanocortins in peripheral nerve disease. Trends Pharmacol. Sci. 11:1990;221-222.
9. Hamers F.P.T., Gerritsen van der Hoop R., Steerenburg P.A., Neijt J.P., Gispen W.H. Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats. Toxicol. Appl. Pharmacol. 111:1991;514-522.
10. Hamers F.P.T., Gispen W.H., Neijt J.P. Neurotoxic side effect of cisplatin. Eur. J. Cancer. 27:1991;372-376.
11. (4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs. Eur. Arch. Otorhinolaryngol. 251:1994;23-29.
12. Kohn S., Fradis M., Podoshin L., David Y.B., Zidan J., Robinson E., Nir I. Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. Laryngoscope. 101:1991;709-716.
13. Konishi T., Gupta B.N., Prazma J. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs. Am. J. Otolaryngol. 4:1983;18-26.
14. Laurell G., Bagger-Sjöbäck D. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol.(Stockh.). 111:1991;891-898.
15. Laurell G., Engström B. The combined effect of cisplatin and furosemide on hearing function in guinea pigs. Hear. Res. 38:1989;19-26.
16. Laurell G., Engström B. The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear. Res. 38:1989;27-34.
17. McAlpine D., Johnstone B.M. The ototoxic mechanism of cisplatin. Hear. Res. 47:1990;191-204.
18. Otto W.C., Brown R.D., Gage-White L., Kupetz S., Anniko M., Penny J.E., Henly C.M. Effects of cisplatin and thiosulphate upon auditory brainstem responses of guinea pigs. Hear. Res. 35:1988;79-86.
19. Pfeifle C.E., Howell S.B., Felthouse R.D., Woliver T.B.S., Andrews P.A., Markman M., Murphy M.P. High-dose cisplatin with sodium thiosulfate protection. J. Clin. Oncol. 3:1985;237-244.
20. Schweitzer V.G. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope. 103:(Suppl. 59):1993;1-52.
21. Stengs C.H.M., Klis S.F.L., Huizing E.H., Smoorenburg G.F. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig. Hear. Res. 111:1997;103-113.
22. Stengs, C.H.M., Klis, S.F.L., Huizing, E.H., Smoorenburg, G.F., 1998. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs. Hear. Res. 124, 99-106.
23. van Deelen G.W., Smoorenburg G.F. Electrocochleography for different electrode positions in guinea pigs. Acta Otolaryngol. (Stockh.). 101:1986;207-216.
24. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8:1996;1897-1905.